Invention Grant
- Patent Title: Compositions and methods for selective delivery of oligonucleotide molecules to cell types
-
Application No.: US14438869Application Date: 2013-10-25
-
Publication No.: US09938525B2Publication Date: 2018-04-10
- Inventor: Maria del Carmen Carmona Orozco , Andrés Pablo Montefeltro , Gabriel G. Alvarado , Analia Bortolozzi , Raquel Revilla-Sanchez
- Applicant: nLife Therapeutics, S.L.
- Applicant Address: ES Armilla, Granada
- Assignee: NLIFE THERAPEUTICS, S.L.
- Current Assignee: NLIFE THERAPEUTICS, S.L.
- Current Assignee Address: ES Armilla, Granada
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: EP12382413 20121026
- International Application: PCT/EP2013/072411 WO 20131025
- International Announcement: WO2014/064258 WO 20140501
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/711 ; A61K31/7088 ; A61K31/713 ; C07K5/065 ; A61K31/165 ; A61K47/54 ; A61K47/55 ; A61K47/64

Abstract:
The invention provides a conjugate comprising (i) a nucleic acid which is complementary to a target nucleic acid sequence and which expression prevents or reduces expression of the target nucleic acid and (ii) a selectivity agent which is capable of binding with high affinity to a receptor which can be internalized by the cell in response to the binding of said selectivity agent. The conjugates of the present invention are useful for the delivery of the nucleic acid to cell of interests and thus, for the treatment of diseases which require a down-regulation of the protein encoded by the target nucleic acid as well as for the delivery of contrast agents to the cells for diagnostic purposes.
Public/Granted literature
- US20150315575A1 COMPOSITIONS AND METHODS FOR SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO CELL TYPES Public/Granted day:2015-11-05
Information query
IPC分类: